More Biotech Dollars to Dane County

Another Biotech Company announces plans to move its facilities and money to Dane County. Could it be that tax dollar central is poised to become the new economic engine for the entire Dairy State?

Caden Biosciences, Inc. Receives a $5.85 Million Series A Financing: Caden Biosciences, Inc., a life sciences tools and services company developing assays for the high-throughput screening of allosteric modulators of G-Protein Coupled Receptors (GPCRs), has closed on a Series A Preferred Stock financing led by Baird Venture Partners (BVP), the U.S.-based venture capital affiliate of investment firm Robert W. Baird & Co. (Baird). BVP was joined in the financing by new investors including Venture Investors, The State of Wisconsin Investment Board, and IllinoisVENTURES, LLC., as well as existing investor Vanderbilt University.

Pete Shagory of BVP and Paul Weiss, PhD, representing the interests of Venture Investors, will join the company's Board of Directors. The company also announced its plan to relocate its headquarters to Madison, Wis.

G-Protein Coupled Receptors are … well … OK the wikipedia explanation: “a protein family of transmembrane receptors that transduce an extracellular signal (ligand binding) into an intracellular signal”. The key is that the chemistry of life involves an interaction between molecules outside of cells and molecular pathways inside of cells. There are a whole lot of people trying to figure out how to get rich by finding something that fixes the biochemistry when life breaks down into disease.

Biotech support pays dividends: UW-Madison's prowess in biotechnology research is a chief reason. The Institute for Scientific Information ranked UW-Madison No. 1, by research citations, in biotechnology and microbiology. Businesses are being created from the university's research. Businesses are also locating here to take advantage of the university's expertise, to tap into the educated labor force the university is producing and to take advantage of the cross-pollination that a burgeoning biotechnology community can provide.

There are big dollar reasons why Doyle is using Stem Cell Research against Green.